コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d by a 5, 6, or 7 membered carbocycle to the quinoline.
2 cantly greater than those of quinolino[7,8-h]quinoline.
3 d selectively the E-isomer of pyrimido[1,6-a]quinoline.
4 (26) is more superbasic than quinolino[7,8-h]quinoline.
5 ygen atom from N-oxide to the C3 position of quinolines.
6 emoselectivity for the synthesis of 8-benzyl quinolines.
7 oration and hydrosilylation of pyridines and quinolines.
8 tetrahydroquinolines into the corresponding quinolines.
9 y the synthesis of pharmaceutically relevant quinolines.
10 ecently published results focused on related quinolines.
11 ng this amidated product into functionalized quinolines.
12 indole derivatives, tyrosine analogues, and quinolines.
13 alkyl quinolines as well as more common aryl quinolines.
14 ing closure to yield hydroxynaphthalenes and quinolines.
15 rogenation of tetrahydroquinolines to afford quinolines.
16 2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-f]-quinoline ((+/-)-(11)C-YJH08), a radioligand for PET tha
18 ogen derivatives 4,9-dichloroquinolino[7,8-h]quinoline (16) and 4,9-dibromoquinolino[7,8-h]quinoline
19 uinoline (16) and 4,9-dibromoquinolino[7,8-h]quinoline (17) as precursors has granted the formation o
20 od involves the Ugi-4CR of 2-chloro-3-formyl quinolines 1a-h, amines 2a-d, 2-chloroacetic acid 3, and
22 d atom economic methods for the synthesis of quinolines, 2-aminoquinolines, and quinazolines via biom
24 design led to the identification of 3-pentyl-quinoline-2-amine as a novel, human TLR8-specific agonis
26 the kynurenic acid analog 7-chloro-4-oxo-1H-quinoline-2-carboxylic acid (7-chlorokynurenic acid; 7-C
29 n-3-yl]-2-methyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline -3-carboxamide; MQC) dose-dependently suppress
31 we show the synthesis of the tetrazolo[1,5-a]quinoline-3-carbaldehyde and tetrazolo[1,5-a]quinoline-3
32 -activity relationships, and binding mode of quinoline-3-carbohydrazide derivatives as allosteric mod
33 (4-methyl-1,4-diazepan-1- yl)sulfonyl)phenyl)quinoline-3-carbonitrile (NEU-924, 83) for T. cruzi and
34 1S)-1-(1-methyl-1H-pyrazol-3-yl)e thyl]amino}quinoline-3-carboxamide (74) as potent and highly select
35 quinoline-3-carbaldehyde and tetrazolo[1,5-a]quinoline-3-dimethyl acetal at room temperature in metha
36 rmacokinetic profile of 2,3,4-trisubstituted quinoline, 4, led to the discovery of two potent, select
37 (4),N(4),N(9),N(9)-tetraethylquinolino[7,8-h]quinoline-4,9-diamine (26) is more superbasic than quino
38 ion of a phenotypic screening hit based on a quinoline-4-carboxamide derivative resulted in the highl
39 amoyl)-phenyl)-6,8-dimethyl-2-(pyridin-2- yl)quinoline-4-carboxamide], a selective GPR55 antagonist.
41 l 8-bromo-1,3,4,5-tetrahydropyrrolo[4,3,2-de]quinoline-4-carboxylate via a conjugate addition/intramo
43 no-4-(4-fluorophenylamino)-1H-pyrazolo[4,3-c]quinoline (42) combined with chemotherapeutic CPT-11 tre
44 of pore-size in a coordination network, [Cu(quinoline-5-carboxyate)2 ]n (Qc-5-Cu) ena+bles ultra-hig
45 ime, 10-dimethylamino derivatives of benzo[h]quinoline 6 and benzo[h]quinazoline 7a-e as mixed analog
46 l)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide monohydrate]] (galunisertib) (IC
47 cation of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity
48 ture determination of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystallized with DYRK1A
49 yl-3',4'-dihydro-1'H-spiro[cyclopropane-1,2'-quinoline] (6) and 6'-chloro-1'-methyl-3',4'-dihydro-1'H
50 yl-3',4'-dihydro-1'H-spiro[cyclopropane-1,2'-quinoline] (7) are 3.5 x 10(2) s(-1) and 4.1 x 10(2) s(-
52 o-2,3-dihydro-1,4-dioxino[2,3-g]thieno[2,3-b]quinoline-8 -carboxamide (8), inhibited this interaction
53 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8- sulfonamide) have the combined properties o
54 henyl)-3a,4,5,9b-te-trahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (2,3,5,6TMP-TQS), previously pub
55 p-tolyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4MP-TQS), together with all oth
56 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (GAT107) and 3-(3,4-difluorophen
57 trahydro-4-(1-naphthalenyl)-3H-cyclopentan[c]quinoline-8-sulfonamide (TQS) and the alpha7 ago-PAM 4BP
58 trahydro-4-(1-naphthalenyl)-3H-cyclopentan[c]quinoline-8-sulfonamide were also linear and showed no c
59 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide), consistent with AA site involv
60 phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide, is a strong positive allosteric
61 henyl)-3a,4,5,9b-te-trahydro-3H-cyclopenta[c]quinoline-8-sulfonamide, originally reported to lack act
62 effect a three-component reaction between a quinoline, a terminal alkyne, and ethyl chloroformate.
63 ion of a variety of N-heteroarenes including quinolines, acridines, benzo[h], and 1,5-naphthyridine a
64 , we report on the effects of pyrazolo[4,3-c]quinolines acting as a new class of bacterial betaG-spec
66 ect remote C-H carboxylation of naphthyl and quinoline amides was developed using CBr(4) and alcohol.
68 ded to the synthesis and isotope labeling of quinoline and 1,2,3,4-tetrahydroquinoline derivatives.
71 licenes were synthesized utilizing versatile quinoline and 9-(2-ethylhexyl)-2,7-dimethoxycarbazole-3-
72 ogen bond catalysts bind to the electrophile quinoline and activate it by lowering its LUMO energy, w
73 Potency was enhanced by methylation of the quinoline and by introduction of simple chiral moieties,
74 ew styryl dyes derived from 4-pyridine and 4-quinoline and having an ammonioalkyl N-substituent and b
75 s, revealing that high quantum yields of the quinoline and isoquinoline derivatives are a result of t
77 Structure-activity relationships in both the quinoline and naphthyridine series leading to the identi
82 (last on August 21, 2017) for studies of the quinoline and structurally related antimalarials for mal
83 ular study revealed the necessity of hydroxy quinoline and the amine group for La(3+) ion binding and
85 ch for the synthesis of 3-aryl-2-substituted quinolines and 4-arylacridines has been developed via th
86 c approach for the synthesis of indolo[2,3-b]quinolines and benzothieno[2,3-b]quinolines has been dev
87 ss to provide the corresponding indolo[2,3-b]quinolines and benzothieno[2,3-b]quinolines, respectivel
89 r exploitation in targeting more embellished quinolines and isoquinolines and complex platforms embod
91 approach of general applicability to diverse quinolines and isoquinolines via a tactic that utilizes
94 able, and practical synthesis of substituted quinolines and pyrimidines using combinations of 2-amino
95 alization of alcohols to various substituted quinolines and quinazolin-4(3H)-ones under relatively mi
99 lines in the presence of tert-butyl nitrite, quinoline, and the Sc(OTf)3 catalyst in DCE at 80 degree
100 ylation of substituted tetrahydroquinolines, quinolines, and 3,4-dihydro-2-quinolinones at most posit
101 multifunctional naphthalenes, phenanthrenes, quinolines, and benzo[b]carbazoles via Knoevenagel conde
102 tron-deficient N-heterocycles (isoquinoline, quinolines, and quinoxalines) and methylbenzenes leading
103 soquinoline derivatives differ from those of quinolines, and the most pronounced differences are foun
104 activity of several isomeric protonated (iso)quinoline- and acridine-based biradicals was examined.
107 d in situ surface observations and show that quinoline antimalarials inhibit beta-hematin crystal sur
108 tion, classical or nonclassical; and whether quinoline antimalarials inhibit crystallization by seque
110 ed sensitivity to chloroquine and some other quinoline antimalarials, but exhibit no or minimal chang
114 ium carbonate modified with lead acetate and quinoline are widely employed industrially for the parti
118 o be facilitated by harnessing the substrate quinoline as an N-ligand, and evidence of the palladium-
121 ilar pocket at the IN dimer interface as the quinoline-based ALLINIs, the lead compound, 5, inhibited
127 Herein, we present our research toward novel quinoline-based hFP-R antagonists, including synthesis a
134 eport design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) in
139 gas-phase reactivities of several protonated quinoline-based sigma-type (carbon-centered) mono-, bi-,
141 cascade delivering a series of pyrrolo[1,2-a]quinolines bearing phosphonate or phosphine oxide moieti
142 rido[1,2-a] benzimidazole, benzimidazo[1,2-a]quinolines, benzimidazo [1,2-a]pyrazine, benzo[4,5] imid
143 described for the synthesis of various fused quinoline, benzoquinoline, and naphthoquinoline derivati
144 o these FIT-PNAs, we have introduced the bis-quinoline (BisQ) cyanine dye that emits light in the red
145 etrazolyl)quinolines or 1,2,3-triazolo[1,5-a]quinoline by conventional flash vacuum pyrolysis (FVP) w
148 epared a number of di- and trifunctionalized quinolines by selective metalation of chloro-substituted
149 odies a quaterpyridine backbone but with the quinoline C8 providing an additional sp(2) center separa
150 The NPAHs 1,4-dihydro(iso)quinoline and (iso)quinoline can be synthesized through reaction of pyridyl
153 ze this intermediate to the pyrrolo[4,3,2-de]quinoline characteristic of the lymphostins resulted in
156 ivity in the regioselective hydrogenation of quinoline, compared with PtNPs of 5.3 nm, allowing the r
157 fungal metabolite brefeldin A (BFA) and the quinoline compound Golgicide A (GCA) inhibited HSV-1 ent
159 sciplinary approaches, we identified a novel quinoline core ligand, BMPQ-1, which bound to human telo
164 strategy, a library of 5-methyl-indolo[3,2-c]quinoline derivatives (IQc) with a range of alkyldiamine
169 In this study, a new series of more than 60 quinoline derivatives has been synthesized and evaluated
172 in 2-(2-vinylstyryl)oxazoles to form benzo[f]quinoline derivatives proceeds on the S1 PES via a stepw
173 ly obtained pK(aH) values of quinolino[7,8-h]quinoline derivatives show that N(4),N(4),N(9),N(9)-tetr
174 strategies toward the synthesis of bioactive quinoline derivatives such as chloroquine analogues.
179 lled C(sp(3))-H arylation using pyridine and quinoline derivatives: The former promotes exclusive mon
180 the generation of a variety of indolo[2,3-b]quinolines derivatives in good to moderate yields with a
181 amily of potential autophagy blockers is the quinoline-derived antimalarial family, including chloroq
184 alkaloid core is efficiently prepared from a quinoline, employing a method which relies on a newly de
186 prised of an NHS-carbamate reactive group, a quinoline fluorophore, and a tertiary amine for enhancin
188 ort the first synthesis of 2,3-disubstituted quinolines from anilines and aromatic or aliphatic epoxi
189 gioselective synthesis of C-3-functionalized quinolines from azadienes (in situ generated from 2-amin
191 as (ii) the presence of the nitrogen on the quinoline group, and (iii) of a hydrophobic group on the
193 lithium reagents to non-activated imines and quinolines has been accomplished in green, biorenewable
194 ndolo[2,3-b]quinolines and benzothieno[2,3-b]quinolines has been developed by employing the freshly p
195 II) ion detection reagent, 10-hydroxybenzo[h]quinoline (HBQ), with an optical field enhanced silicon
197 f 10 3-imidazo[1,2-a]pyridin-tetrazolo[1,5-a]quinolines in 28-94% yields via a novel one-pot Groebke-
199 good to excellent yields on the platform of quinolines in the presence of KOH in aqueous media at ro
200 ade sequence to access highly functionalized quinolines including the core structures of an antiproto
201 ding pyrimidines, N-substituted piperidines, quinolines, indoles, N-substituted imidazoles, triazoles
202 s an N-ligand, and evidence of the palladium-quinoline interaction is provided by (1)H-(15)N HMBC NMR
204 -IQ) formed by 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), a highly mutagenic and carcinogenic hete
208 e structure-based design and optimization of quinoline lead compounds to identify FT-2102, a potent,
210 covery of chiral acetyl-protected aminoethyl quinoline ligands that enable asymmetric palladium inser
211 f the readily available 8-hydroxy- or 8-thio-quinoline ligands, which are well known for their strong
218 ly reported the therapeutic potential of the quinoline methanol Vacquinol-1 (1) that targets glioblas
219 pment of antileishmanial agents, a series of quinoline-metronidazole hybrid compounds was synthesized
220 hmanial lead and emphasize the importance of quinoline-metronidazole series as a suitable platform fo
221 state places significant spin density on the quinoline moiety of the 1-isocyTPQA ligand positioned tr
226 strated by gram scale synthesis of C-8 amide quinoline N-oxide and by converting this amidated produc
227 study revealed five-membered rhodacycle with quinoline N-oxide as a key intermediate for regioselecti
229 II)-catalyzed C-8 selective C-H amidation of quinoline N-oxide using dioxazolone as an amidating reag
231 o-triphenylmonoquinoline-annulated porphyrin quinoline N-oxide, possessing a slightly shifted and sha
233 ynthesis of various 2-anilinoquinolines from quinoline N-oxides and aryldiazonium salts in acetonitri
235 bstrates and by converting the C8-olefinated quinoline N-oxides into various other useful molecules.
238 a family of closely related pyrrolo[4,3,2-de]quinoline natural products produced by Streptomyces and
239 between the phenol oxygen (proton donor) and quinoline nitrogen (proton acceptor), dO...N, giving ris
242 hibitors were added to P450 3A4 in 7-benzoyl quinoline O-debenzylation reactions, and similar pattern
245 icient preparation of selected pyrrolo[1,2-a]quinolines on multigram scale without any safety concern
246 f either a 2-oxo-1,2-dihydropyrrolo[4,3,2-de]quinoline or an unusual N,C-linked tetrahydropyrroloquin
247 ethylquinolines generated from (5-tetrazolyl)quinolines or 1,2,3-triazolo[1,5-a]quinoline by conventi
248 hydrocarbons (aza-(P)AHs; namely, pyridine, quinoline, phenanthridine, and benzo[d]thiazole) is repo
251 rid-2'-yl)-8-(1'',10''-phenanthrolin-2''-yl)-quinoline (ppq) embodies a quaterpyridine backbone but w
252 (1'',10''-phenanthrol-2''-yl)-2-(pyrid-2'-yl)quinoline (ppq), has been prepared by two sequential Fri
253 rom Hantzsch ester, a weak Bronsted acid, to quinoline prior to hydride reduction was identified as t
254 scope of both heterocyclic arenes (pyridine, quinoline, pyrazole, imidazole, furan, thiophene, benzof
255 n-containing aromatics, including pyridines, quinolines, pyrimidines, various azoles and the derivati
256 bioactive heterocyclic backbones containing quinoline, pyrrolidone, and beta-lactam with high bond-f
257 logy is further demonstrated in synthesis of quinoline-quinolone hybrid as well as 6-aryl-benzofuro[3
258 iosynthesized by (18)F-introduction onto the quinoline rather than the pyrazole moiety of the MP-10 p
260 ndolo[2,3-b]quinolines and benzothieno[2,3-b]quinolines, respectively, in moderate to excellent yield
261 vealed that the geometric disposition of the quinoline ring at the C8 chiral carbon of cinchona-enami
262 AR) of the 4-, 6-, and 8-substituents of the quinoline ring resulted in the identification of approxi
263 e former originates from the presence of the quinoline ring, which slows the formation of the off-cyc
265 design of this series centered on morphing a quinoline series recently disclosed in the patent litera
266 nhibition with the model substrate 7-benzoyl quinoline showed lag phases in several cases, consistent
268 oups with respect to both the alkyne and the quinoline starting materials and the products are easily
269 addition to the C4 position of 4-substituted quinoline substrates, with subsequent Hantzsch ester-pro
271 first generation of fluoroalkyl-substituted quinoline tau binding ligands with suboptimal physicoche
272 as palladium-catalyzed coupling to generate quinolines that can be substituted at every position of
273 thereby completing S(N)(H)Ar reaction, with quinolines, the reaction stops at the formation of the a
275 it is preferable to lower the LUMO energy of quinoline through protonation by Hantzsch ester as a Bro
276 cyclopentenyl ring to the plane of the core quinoline to be a crucial determinate of PAM activity.
277 oaddition, using sulfonyl azide, alkyne, and quinoline, to prepare pyrimido[1,6-a]quinolines is repor
279 component Povarov reaction forms 2,3-dialkyl quinolines under the same green conditions that enable t
283 reductive functionalization of pyridines and quinolines using catalytic iridium; thus, inexpensive an
284 he synthesis of densely substituted 4-alkoxy quinolines via an oxonium ion triggered alkyne carboamin
286 (4-(2,4-dinitrophenylsulfonyl)piperazin-1-yl)quinoline (VR23) as a small molecule that potently inhib
287 edlander and Combes syntheses of substituted quinolines were conducted in charged microdroplets produ
288 ing cholesterol derivatives, and substituted quinolines were obtained in good yields by using a minut
290 A series of 18 3-tetrazolyl-tetrazolo[1,5-a]quinolines were synthesized in 21-90% yields via a novel
291 d N10,O11-bis-alkylamine (3a-k) indolo[3,2-b]quinolines, were evaluated for their in vitro activity a
294 of unactivated C(sp(3))-H bonds of 8-methyl quinolines with arylboronic acids to synthesize diarylme
296 y selective metalation of chloro-substituted quinolines with metal amides followed by reaction with d
297 ielding dearomative C-4 functionalization of quinolines with organometallics with nearly absolute reg
299 cluding Tartrazine (E102), Chrysoine (E103), Quinoline Yellow (E104), Yellow 2G (E107), Sunset Yellow